Holen Sie sich die Stockscreener-App
15.50
1.55%
0.2837
Schlusskurs vom Vortag:
$15.22
Offen:
$15.1
24-Stunden-Volumen:
287.13K
Relative Volume:
0.45
Marktkapitalisierung:
$629.95M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-168.05M
KGV:
-3.0222
EPS:
-5.13
Netto-Cashflow:
$-146.15M
1W Leistung:
+1.81%
1M Leistung:
-3.04%
6M Leistung:
+5.50%
1J Leistung:
-74.22%
1-Tages-Spanne:
$15.10
$15.55
1-Wochen-Bereich:
$14.86
$15.55
52-Wochen-Spanne:
$9.12
$72.37
Keros Therapeutics Inc Stock (KROS) Company Profile
Firmenname
Keros Therapeutics Inc
Sektor
Branche
Telefon
617-314-6297
Adresse
1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA
Vergleichen Sie KROS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KROS
Keros Therapeutics Inc
|
15.51 | 463.69M | 0 | -168.05M | -146.15M | -5.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.25 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
635.15 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
428.04 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
842.63 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
185.81 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Keros Therapeutics Inc Stock (KROS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-20 | Eingeleitet | Wells Fargo | Overweight |
| 2025-06-10 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-01-21 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-01-17 | Herabstufung | Wedbush | Outperform → Neutral |
| 2024-12-16 | Herabstufung | Guggenheim | Buy → Neutral |
| 2024-12-16 | Bestätigt | Oppenheimer | Outperform |
| 2024-12-13 | Bestätigt | H.C. Wainwright | Buy |
| 2024-12-12 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-12-12 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-12-12 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-11-05 | Eingeleitet | Jefferies | Buy |
| 2024-10-24 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-09-23 | Eingeleitet | Guggenheim | Buy |
| 2024-06-25 | Eingeleitet | Oppenheimer | Outperform |
| 2024-02-21 | Eingeleitet | William Blair | Outperform |
| 2023-12-08 | Eingeleitet | Wells Fargo | Overweight |
| 2023-07-31 | Eingeleitet | Wedbush | Outperform |
| 2023-07-26 | Eingeleitet | BofA Securities | Buy |
| 2023-02-14 | Eingeleitet | Cowen | Outperform |
| 2022-10-18 | Eingeleitet | Truist | Buy |
| 2022-07-26 | Eingeleitet | BTIG Research | Buy |
| 2020-12-08 | Bestätigt | H.C. Wainwright | Buy |
| 2020-05-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-05-04 | Eingeleitet | Jefferies | Buy |
| 2020-05-04 | Eingeleitet | Piper Sandler | Overweight |
| 2020-05-04 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Keros Therapeutics Inc Aktie (KROS) Neueste Nachrichten
Will Keros Therapeutics Inc. price bounce be sustainableAnalyst Downgrade & Expert Curated Trade Ideas - newser.com
Is Keros Therapeutics Inc. stock reversal real or fake2025 Top Decliners & Community Verified Trade Alerts - newser.com
Will Keros Therapeutics Inc. stock return to pre crisis levelsWeekly Investment Summary & High Conviction Buy Zone Alerts - newser.com
Evaluating Keros Therapeutics Inc. with trendline analysisTrade Risk Report & Target Return Focused Stock Picks - newser.com
Published on: 2025-11-03 06:15:55 - newser.com
Why Keros Therapeutics Inc. stock remains undervalued2025 Price Action Summary & Weekly Market Pulse Alerts - newser.com
Can volume confirm reversal in Keros Therapeutics Inc.2025 Historical Comparison & Reliable Price Breakout Signals - newser.com
Will a bounce in Keros Therapeutics Inc. offer an exitJuly 2025 PostEarnings & Detailed Earnings Play Strategies - newser.com
Y Intercept Hong Kong Ltd Invests $1.40 Million in Keros Therapeutics, Inc. $KROS - MarketBeat
How to recover losses in Keros Therapeutics Inc. stock2025 Winners & Losers & High Accuracy Trade Alerts - newser.com
Reversal indicators forming on Keros Therapeutics Inc. stockJuly 2025 Sentiment & Expert Verified Movement Alerts - newser.com
What hedge fund activity signals for Keros Therapeutics Inc. stockMarket Volume Report & Verified Trade Idea Suggestions - newser.com
Can trapped investors hope for a rebound in Keros Therapeutics Inc.Bull Run & Daily Risk Controlled Trade Plans - newser.com
How to manage a losing position in Keros Therapeutics Inc.Product Launch & Safe Entry Zone Tips - newser.com
Will Keros Therapeutics Inc. stock rally after Fed decisionsJuly 2025 Intraday Action & Safe Entry Point Alerts - newser.com
Published on: 2025-11-02 04:38:21 - newser.com
How interest rate cuts could boost Keros Therapeutics Inc. stockRate Hike & Breakout Confirmation Alerts - newser.com
Will Keros Therapeutics Inc. stock deliver consistent dividendsPortfolio Profit Report & Low Risk Profit Maximizing Plans - newser.com
Published on: 2025-11-01 09:22:31 - newser.com
Is Keros Therapeutics Inc. stock resilient to inflationQuarterly Growth Report & AI Forecast Swing Trade Picks - newser.com
Keros Therapeutics Inc expected to post a loss of $1.05 a shareEarnings Preview - TradingView
Keros Therapeutics, Inc. Experiences Revision in Its Stock Evaluation Amid Market Challenges - Markets Mojo
Keros Therapeutics (KROS) to Release Quarterly Earnings on Wednesday - MarketBeat
Is Keros Therapeutics Inc. stock attractive for income investorsJuly 2025 Closing Moves & High Accuracy Trade Alerts - newser.com
Keros Therapeutics Stock Fell 6.4% in a Month, What Now? - Trefis
How Keros Therapeutics Inc. stock reacts to bond yieldsPortfolio Profit Report & Daily Entry Point Trade Alerts - fcp.pa.gov.br
Published on: 2025-10-28 02:25:47 - newser.com
Finanzdaten der Keros Therapeutics Inc-Aktie (KROS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.71%
0.18%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):